Results 231 to 240 of about 7,228,361 (402)
Computer analysis of microbial molecular typing data (ESCMID European Study Group on Epidemiological Markers) [PDF]
openalex +1 more source
Small extracellular vesicles are a promising source of diagnostic molecules. We conducted a comprehensive study, including transcriptome profiling and RT‐qPCR validation on large cohorts of samples. Diagnostic panels enabling sensitive detection of colorectal cancer and precancerous lesions were established. Some molecules were differentially expressed
Petra Vychytilova‐Faltejskova+26 more
wiley +1 more source
Correction: Quantitative trait loci analysis for molecular markers linked to agricultural traits of Pleurotus ostreatus. [PDF]
Ryu JS+4 more
europepmc +1 more source
A molecular marker for centriole maturation in the mammalian cell cycle.
Bodo Lange, Keith Gull
openalex +1 more source
β‐TrCP overexpression enhances cisplatin sensitivity by depleting BRCA1
Low levels of β‐TrCP (Panel A) allow the accumulation of BRCA1 and CtIP, which facilitate the repair of cisplatin‐induced DNA damage via homologous recombination (HR) and promote tumor cell survival. In contrast, high β‐TrCP expression (Panel B) leads to BRCA1 and CtIP degradation, impairing HR repair, resulting in persistent DNA damage and apoptosis ...
Rocío Jiménez‐Guerrero+8 more
wiley +1 more source
Molecular Markers in Oral Lichen Planus - Insight into Pathogenesis. [PDF]
Mutafchieva MZ, Draganova MN, Tomov GT.
europepmc +1 more source
Multipoint Mapping of Viability and Segregation Distorting Loci Using Molecular Markers [PDF]
Claus Vogl, Shizhong Xu
openalex +1 more source
Stemness properties, including quiescence, self‐renewal, and chemoresistance, are closely associated with leukemia relapse. Here, we demonstrate that DNA damage‐inducible transcript 4 (DDIT4) is induced in the hypoxic bone marrow niche and is essential for maintaining the stemness of AML1‐ETO9a leukemia cells.
Yishuang Li+12 more
wiley +1 more source
Molecular markers for the efficacy of neoadjuvant immunotherapy for head and neck squamous cell carcinoma. [PDF]
Zhu J, Ning Y.
europepmc +1 more source